Th1/Th2细胞在慢性乙型肝炎急性发作的免疫应答研究
详细信息    本馆镜像全文|  推荐本文 |  |   获取CNKI官网全文
摘要
目的: 通过检测慢性乙型肝炎急性发作患者外周血Th1及Th2细胞的百分比及Th1/Th2的比值、乙型肝炎病毒(HBV)DNA载量以及肝功能的状况,了解在乙型肝炎病毒复制及肝细胞受损时Th1/Th2细胞免疫应答的变化情况 。
    方法:研究对象为正常对照组19例,慢性乙型肝炎急性发作组17例。应用流式细胞仪测定外周血中淋巴细胞胞浆内含白细胞介素-4(IL-4)及干扰素-γ(IFN-γ)的细胞的百分比及比值,采用荧光定量聚合酶链反应技术(FQ-PCR),检测慢性乙型肝炎患者发作时及治疗后外周血清中HBV DNA的载量;应用全自动生化分析仪检测患者急性发作及治疗后血清中丙氨酸氨基转移酶(ALT)、天门冬氨酸氨基转移酶(AST)的活性和血清总胆红素(TB)的含量。
    结果:(1)在慢性乙型肝炎急性发作时Th1细胞百分比(14.52±4.86%)明显高于治疗后(9.33±2.72%)(P<0.05),也比正常对照组高(9.92±4.54%)(P<0.05);急性发作时Th2细胞百分比(1.64±0.59%)与治疗后(1.81±0.75%)相比较无显著性差异(P>0.05),与正常对照组(2.058±0.985%)相比较也无显著性差异;急性发作时Th1/Th2比值比正常对照组高(P<0.05),也比治疗后Th1/Th2比值高(P<0.05), 治疗后Th1/Th2比值与正常对照组相比较,无显著性差异(P>.05);(2)慢性乙型肝炎急性发作时HBV DNA含量(经log转换后)为7.87±1.96copies/ml,治疗后为5.45±1.95 copies/ml,两者相比较有显著性差异(P<0.05);(3)急性发作时ALT为467.52±103.46U/L,治疗后为137.66±53.29 U/L,两者相比较有显著性差异(P<0.05);(4)Th1细胞比例与ALT活性呈正相关关系(r=0.432, P<0.05);,Th1/Th2比值与ALT活性呈正相关关系(r=0.493,P<0.05); Th1细胞比例与HBV DNA含量及
    
    
    肝功能其他指标均无明显相关关系。
    结论:(1)慢性乙型肝炎急性发作时Th1细胞比例与肝炎活动程度呈正相关;(2)慢性乙型肝炎急性发作与Th1/Th2的失衡密切相关。(3)Th1细胞比例测定可作为动态监测肝炎活动的有效指标之一。
To investigate the immune response of Th1/Th2 cells to HBV duplication and subsequent injury of liver cells through detection of Th1/Th2 cells’ ratio, HBV DNA load and liver function indexes in peripheral blood of chronic hepatitis B patients during acute exacerbation.
    Methods: 19 cases of normal controls and 17 cases of chronic hepatitis B patients experiencing acute exacerbation were recruited into this study. Using flow cytometry assay, Th1/Th2 ratio was estimated by quantification of cytokins (IL-4, r-IFN) inside the plasma of single CD4+ T cells. HBV DNA load in peripheral serum of chronic HBV infectants during and after acute exacerbation period was analyzed by polymerase chain reaction (PCR) assay combined with fluorescent probe (FQ-PCR). Liver function indexes (ALT,AST,TB) during acute exacerbation and after treatment was estimated by Hitachi 7170A auto-chemistry analyzer. Results: (1) The percentage of Th1 cells(14.52±4.86%) in chronic HBV infectants during acute exacerbation was higher than that these patients after treatment(9.33±2.72%)(P<0.05) and that of normal controls(9.92±4.54%)(P<0.05). Similarly, the ratio of Th1/Th2 during acute exacerbation was higher than that of normal controls (P<0.05) and that these patients after treatment (P<0.05). There was no statistic difference of Th2 cells percentage between cases and controls(P>0.05). Also, there was no statistic difference of Th1/Th2 ratio between normal controls and cases after treatment (P>0.05). There was no statistic difference of Th2 cells percentage between patients before(1.64±0.59%) and after treatment(1.81±0.75%), and between patients (1.64±0.59%)and controls(2.05±0.98%). (2) HBV DNA load of chronic HBV infectants during acute exacerbation (7.87±
    
    
    1.96copies/ml,log transformed) was higher than that these patients after treatment(5.45±1.95)(P<0.05). (3) ALT activity during acute exacerbation (467.52±103.46U/L) were significant higher than that these patients after treatment (137.66±53.29 U/L) (P<0.05). (4) The ratio of both Th1 (r=0.432, P<0.05) and Th1/Th2 (r=0.493, P<0.05) were positively associated with ALT activity. Nevertheless, The percentage of Th1 cells was not significantly associated with either HBV DNA load or other liver function indexes.
    Conclusions: (1) The percentage of Th1 cells in chronic HBV infectants during acute exacerbation is positively associated with the severity of hepatitis. (2) The aberration of Th1/Th2 ratio is closely associated with acute exacerbation of chronic HBV infectants. (3) The percentage of Th1 cells is potential biomarker for dynamic monitoring of hepatitis.
引文
[1] Mosmann TR, cherwinski H, Bond MW, et al. Two types of murine helper T cell clone: Definition according to profiles of lymphokine activities and secreted proteins . J lmmunol, 1986, 136(4); 2348—2357.
    [2] Maggi E, Biswas P, Del prete G, et al. Accumulation of Th-2-like helper T cells in the conjunctiva of patients with vernal conjunctivitis. J lmmunol ,1991, 146: 1169-74.
    [3] 万谟彬. 慢性乙型肝炎治疗的现状及前景. 中华传染病杂志,2002,20(1):57-59.
    [4] 张泰和,周晓军. 实用肝脏病理学.上海科学技术出版社,1995.41-42
    [5] 张荣春,王爱忠. 慢性乙型肝炎急性发作.现代实用医学,2002,14(7):373-374.
    [6] Liaw YF. Acute exacerbation and superinfection in patients with chronic viral hepatitis .J Formos Med Assoc , 1995,94(9):521-528.
    [7] Perrillo RP. Acute flares in chronic hepatitis B: the natural and unnatural history of an immunologically mediated liver disease. Gastroenterology, 2001,120(4):1009-22.
    [8] 中华医学会传染病与寄生虫病学会肝病学分会.病毒性肝炎防治方案.中华肝脏病杂志,2000,8:324-29.
    [9] Rostaing L , Tkaczuk J , Durand M , et al. Kinetics of intracytoplasmic Th1 and Th2 cytokine production assessed by flow cytometry following in vitro activation of peripheral blood mononuclear cells. Cyctometry ,1999,35:318-328.
    [10] Baran J, Kowalczyk D ,Ozog M. et al .Three-Color Flow Cytometry detection of intracellular cytokines in peripheral blood mononuclear
    
    
    cells: comparative analysis of phorbol myristate acetata-ionomycin and phytohemagglutinin stimulation. Clinical and Diagnostic Laboratory Immunology, 2001,8(2):303-313.
    [11]王少扬.Th1/Th2细胞失衡与慢性乙型肝炎.国外医学流行病学传染病学分册,1998,25:202-204.
    [12] 姜荣龙,卢桥生,侯全林,等。辅助性T细胞极化群体在慢性乙型肝炎病毒感染中的作用. 中华医学杂志,2000,80(10):741-744.
    [13] 周茂华,王丁,张建军,等. 乙型肝炎患者外周血细胞中Th1/Th2型细胞因子的表达及其临床意义. 中国免疫学杂志,2003,19(10)725-727.
    [14] 崔焱,陈煜,贾继东,等. 慢性乙型肝炎患者外周血T辅助细胞1、2亚群与肝内炎症的关系. 临床内科杂志,2002,19(4):297-298.
    [15] Nishimura T, Ohta A. A critical role for antigen-specific Th1 cells in acute liver injury in mices. J Immunol, 1999, 162: 6563-9.
    [16] Guidotti LG ,Matzke B ,Chisari FV. Hepatitis B virus replication is cell cycle independent during liver regeneration in transgenic mice. J Virol, 1997,71:4804-4808.
    [17] Heise T ,Guidotti LG ,Chisari FV. La autoantigen specifically recognizes a predicted stem-loop in hepatitis B virus RNA. J Virol, 1999,73(7):5767-5776.
    [18] Guidotti LG ,McClary H ,Loudis JM , et al. Nitric oxide inhibits hepatitis B virus replication in the livers of transgenic mice. J Exp Med, 2000,191(7):1247-52.
    [19] 周小辉,高志良,姚集鲁. 慢性乙型肝炎病情再活动时血清HBV DNA水平的变化. 中山医科大学学报,2000,21(1):37-39.
    [20] 张树林,刘敏,朱江,等. Th2优势应答与HBV慢感染.世界华人消化杂志,1999,7:513-515.
    [21] 姜荣龙,卢桥生,骆抗先,等. 慢性乙型肝炎病毒感染者外周血T
    
    
    辅助细胞1、2型因子的表达. 中华传染病杂志,2000,18:26-28.
    [22] Pala P, Hussell T, Openshaw PJ . Flow cytometric measurement of intracellular cytokines. J Immunological methods, 2000, 243:107-124.
    [23] 于乐成,顾长海. 乙型肝炎病毒感染慢性化研究进展. 基础医学与临床,1999,19(6):25-32.